Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Neurology(R) Neuroimmunology & Neuroinflammation|September 25, 2020
Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MSOrhan Aktas, Alina Renner, André Huss, et al.Communications Biology|September 21, 2021
Multimodal electrophysiological analyses reveal that reduced synaptic excitatory neurotransmission underlies seizures in a model of NMDAR antibody-mediated encephalitisSukhvir K Wright, Richard E Rosch, Max A Wilson, et al.Brain : a Journal of Neurology|June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunityTobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.Brain Communications|April 30, 2025
Lymphocyte signatures correspond to clinical phenotypes in autoimmune limbic encephalitisSaskia Räuber, Andreas Schulte-Mecklenbeck, Kelvin Sarink, et al.Annals of Clinical and Translational Neurology|November 22, 2017
NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibodyManish Malviya, Sumanta Barman, Kristin S Golombeck, et al.Journal of Neuroinflammation|November 4, 2024
Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignanciesSaskia Räuber, Andreas Schulte-Mecklenbeck, Alice Willison, et al.Science Translational Medicine|January 21, 2026
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosisNadjet Gacem, Svetlana Bezukladova, Farina Windener, et al.Brain : a Journal of Neurology|April 16, 2020
Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosisMichael Dietrich, Valeria Koska, Christina Hecker, et al.Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.Pageof 5